|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010825,
umls-concept:C0017066,
umls-concept:C0029216,
umls-concept:C0332293,
umls-concept:C0348016,
umls-concept:C0376387,
umls-concept:C0440790,
umls-concept:C0442027,
umls-concept:C0524930,
umls-concept:C0683598,
umls-concept:C0909381
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-8-25
|
|
pubmed:abstractText |
The rate of cytomegalovirus (CMV) mutations conferring ganciclovir resistance was assessed in a trial comparing intravenous ganciclovir and oral valganciclovir for treatment of CMV disease in solid organ transplant (SOT) recipients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
697-704
|
|
pubmed:meshHeading |
pubmed-meshheading:19704173-Administration, Oral,
pubmed-meshheading:19704173-Antiviral Agents,
pubmed-meshheading:19704173-Cytomegalovirus,
pubmed-meshheading:19704173-Cytomegalovirus Infections,
pubmed-meshheading:19704173-DNA-Directed DNA Polymerase,
pubmed-meshheading:19704173-Drug Resistance, Viral,
pubmed-meshheading:19704173-Ganciclovir,
pubmed-meshheading:19704173-Humans,
pubmed-meshheading:19704173-Injections, Intravenous,
pubmed-meshheading:19704173-Mutation,
pubmed-meshheading:19704173-Organ Transplantation,
pubmed-meshheading:19704173-Phosphotransferases (Alcohol Group Acceptor),
pubmed-meshheading:19704173-Treatment Outcome,
pubmed-meshheading:19704173-Viral Proteins
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
|
|
pubmed:affiliation |
Infectious Disease Research Center of the Centre hospitalier universitaire de Québec, Québec City, QC, Canada. Guy.Boivin@crchul.ulaval.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
